Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls

The study aimed to evaluate vaccine-related adverse events (VRAEs) following ChAdOx1-nCoV-19 vaccine in solid cancer patients receiving treatment compared to healthy controls. 399 cancer patients and 90 healthy volunteers were enrolled. In the overall population, the incidence of VRAEs was significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakvisal, Nussara, Sainamthip, Panot, Teeyapun, Nattaya, Luangdilok, Sutima, Wanlapakorn, Nassamon, Yorsaeng, Ritthideach, Poovorawan, Yong, Pakvisal, Piyapoom, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Sriuranpong, Virote, Tanasanvimon, Suebpong, Wanchaijiraboon, Passakorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746493/
https://www.ncbi.nlm.nih.gov/pubmed/35776836
http://dx.doi.org/10.1080/21645515.2022.2094149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746493/
https://www.ncbi.nlm.nih.gov/pubmed/35776836
http://dx.doi.org/10.1080/21645515.2022.2094149

Ejemplares similares